Search Orphan Drug Designations and Approvals
-
Generic Name: | Cystic fibrosis transmembrane conductance regulator |
---|---|
Date Designated: | 01/14/1992 |
Orphan Designation: | For cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis patients. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genzyme Corporation One Mountain Road P.O. Box 9322 Framingham, Massachusetts 01701 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-